Integra Issues Recall Of Intracranial Pressure Monitors
Company also adjusts its earnings forecast
Integra LifeSciences has recalled CereLink intracranial pressure monitors because of reports they were providing inaccurate readings. The company adjusted its third quarter earnings expectations in response.
You may also be interested in...
A pair of medical experts discuss traumatic brain injuries, their treatments, and some of the long-term complications they can cause, especially when not properly diagnosed and treated.
The US FDA has labelled a June recall of intracranial pressure monitors from Integra with its most serious designation, class I.
During a recent listening session on modernizing its recall process, the US FDA heard from industry, consumers, and patients — all of whom expressed a common theme: the agency needs to up its game in how it handles recalls.